section name header

Basics

Outline


BASICS

Overview!!navigator!!

  • ACRs are a commonly used class of rodenticides
  • ACRs interfere with normal blood clotting and cause coagulopathy by inhibiting vitamin K epoxide reductase in liver and preventing formation of active clotting factors
  • First-generation anticoagulants such as warfarin, coumafuryl, coumachlor, and coumatetralyl are short-acting, requiring multiple feedings to result in toxicosis
  • Long-acting or second-generation ACRs include chlorophacinone, diphacinone, pindone, brodifacoum, bromadiolone, difethialone, difenacoum, and others. These are more toxic
  • Most ACRs used today are second generation, with activity in the body lasting ~1 month or longer
  • Minimum toxic dosage has not been established in horses. Coagulopathy has been reported in horses associated with a brodifacoum dosage of 0.125 mg/kg, and a diphacinone dosage of 0.2 mg/kg

Signalment!!navigator!!

Poisoning can occur after accidental ingestion of bait or as a result of malicious intent.

Signs!!navigator!!

  • Hemorrhage of variable severity. Can be internal, external, or both, and can be focal or widespread
  • Signs generally manifest within 2–5 days after ingestion and include pale mucous membranes, weakness, anorexia, dyspnea, tachycardia, hematomas and swellings, hematuria, bleeding from the mouth, and epistaxis
  • Signs are delayed and do not occur until days after exposure, after existing clotting factors are depleted

Causes and Risk Factors!!navigator!!

  • Careless bait placement
  • Baits often contain ingredients that are attractive to horses

Diagnosis

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

  • Dicoumarol toxicosis
  • Other causes of coagulopathy

CBC/Biochemistry/Urinalysis!!navigator!!

  • Anemia and hypoproteinemia suggestive of blood loss possible
  • Urinalysis may show the presence of red blood cells

Other Laboratory Tests!!navigator!!

  • Prolonged PT, aPTT, and activated coagulation time. aPTT is reported to increase before PT in horses
  • Chemical analysis of serum, whole blood or liver tissue (postmortem) for specific ACR compounds

Imaging!!navigator!!

Chest radiographs may show evidence of fluid in the chest cavity or hemorrhage within the lungs.

Pathologic Findings!!navigator!!

Hemorrhages may occur in any part of the body and may be focal or widespread.

Treatment

TREATMENT

  • Whole-blood or plasma transfusions to replace clotting factors if patient is actively bleeding. Whole blood is preferred with severe anemia
  • Keep patient confined to stall rest
  • Decontamination with AC and possibly a cathartic via nasogastric tube is appropriate if instituted soon after exposure (within several hours) and the patient is asymptomatic

Medications

Outline


MEDICATIONS

Drug(s) of Choice!!navigator!!

  • Vitamin K1 (phytonadione) 2.5 mg/kg every 24 h or divided into twice daily dosing, given PO or SC and continuing for 3–5 weeks for long-acting ACRs, or 1–2 weeks for short-acting compounds. If ACR compound is unknown, treat as for a long-acting ACR
  • PO administration of vitamin K1 formulated for injection is preferable to SC injection, unless AC has been administered. Mixing vitamin K1 with a small amount of a digestible fat increases absorption. Most injectable formulations of vitamin K1 are well absorbed orally and can be administered orally until compounded vitamin K1 oral solution can be obtained
  • A day or longer may be required for new clotting factor synthesis

Contraindications/Possible Interactions!!navigator!!

  • Do not use vitamin K3 (menadione) in horses. Vitamin K3 is ineffective and nephrotoxic
  • Do not administer vitamin K1 IV as it can cause anaphylactic reaction
  • NSAIDs and other drugs affecting coagulation are contraindicated

Follow-up

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

  • Continued monitoring of coagulation times and blood loss until patient is stable
  • Check clotting times 2–3 days and 5 days after the last dose of vitamin K1 to determine if additional treatment is necessary

Prevention/Avoidance!!navigator!!

  • Prevent access to rodenticide baits
  • Not all rodenticides are anticoagulant compounds. Verify active ingredient if possible before treatment

Possible Complications!!navigator!!

If duration of vitamin K1 therapy is too short, recurrence of coagulopathy can occur.

Expected Course and Prognosis!!navigator!!

  • The prognosis is good if treatment is instituted before coagulopathy occurs
  • The prognosis in patients with active bleeding depends on the severity and speed of hemorrhage, and the site of hemorrhage. Bleeding into the lungs, chest cavity, brain, or cranium can result in rapid death

Miscellaneous

Outline


MISCELLANEOUS

Associated Conditions!!navigator!!

N/A

Age-Related Factors!!navigator!!

N/A

Zoonotic Potential!!navigator!!

N/A

Pregnancy/Fertility/Breeding!!navigator!!

  • Lactating mares may excrete ACR in their milk
  • Monitor foals for coagulopathy, and treat with vitamin K1 if clotting times are elevated. Alternatively, consider weaning the foal from the affected mare and providing an alternative milk supply

Abbreviations!!navigator!!

  • AC = activated charcoal
  • ACR = anticoagulant rodenticide
  • aPTT = activated partial thromboplastin time
  • NSAID = nonsteroidal anti-inflammatory drug
  • PT = prothrombin time

Suggested Reading

Boermans HJ, Johnstone I, Black WD, Murphy M. Clinical signs, laboratory changes and toxicokinetics of brodifacoum in the horse. Can J Vet Res 1991;55:2127.

McConnico RS, Copedge K, Bischoff KL. Brodifacoum toxicosis in two horses. J Am Vet Med Assoc 1997;211:882886.

Author(s)

Author: Cynthia L. Gaskill

Consulting Editors: Wilson K. Rumbeiha and Steve Ensley

Acknowledgment: The author and editors acknowledge the prior contribution of Anita M. Kore.